Neurocrine Biosciences advertising spend, FY2025
Neurocrine Biosciences (NBIX) reported $227M of advertising expense for the fiscal year ended Dec 31, 2025. That is 7.9% of revenue of $2.9B. Up 18.7% from FY2024.
Key facts
- Ad spend is 3.5x its FY2020 level ($64.8M), faster than revenue (2.7x).
- FY2025 is the highest year on file, going back to FY2018.
- Largest increase +115.7% in FY2021.
- Ad spend has risen 7 years in a row.
- Ad spend is 7.9% of revenue, up from 6.2% in FY2020.
- Neurocrine Biosciences spends more on advertising than 37% of the 336 US-listed companies tracked. Its ad-to-revenue ratio is 1.5x the median of 5.2%.
Ad spend by fiscal year
Ad spend as % of revenue
History
Download CSV| Fiscal year | Period end | Ad spend | YoY | Revenue | Ad / revenue | Tag | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | $227M | +18.7% | $2.9B | 7.9% | AdvertisingExpense | 10-K Feb 11, 2026 |
| FY2024 | Dec 31, 2024 | $191M | +19.4% | $2.4B | 8.1% | AdvertisingExpense | 10-K Feb 11, 2026 |
| FY2023 | Dec 31, 2023 | $160M | +6.8% | $1.9B | 8.5% | AdvertisingExpense | 10-K Feb 11, 2026 |
| FY2022 | Dec 31, 2022 | $150M | +7.1% | $1.5B | 10.1% | AdvertisingExpense | 10-K Feb 10, 2025 |
| FY2021 | Dec 31, 2021 | $140M | +115.7% | $1.1B | 12.3% | AdvertisingExpense | 10-K Feb 9, 2024 |
| FY2020 | Dec 31, 2020 | $64.8M | +59.6% | $1B | 6.2% | AdvertisingExpense | 10-K Feb 9, 2023 |
| FY2019 | Dec 31, 2019 | $40.6M | +98.0% | $788M | 5.2% | AdvertisingExpense | 10-K Feb 11, 2022 |
| FY2018 | Dec 31, 2018 | $20.5M | n/a | $451M | 4.5% | AdvertisingExpense | 10-K Feb 5, 2021 |
What the figure is
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Compared with similar spenders
The 6 companies closest to Neurocrine Biosciences in latest-year ad spend.
| Rank | Company | Ad spend | Ad / revenue | YoY | Fiscal year |
|---|---|---|---|---|---|
| 209 | Hertz Global | $230M | 2.7% | -12.9% | FY2025 |
| 210 | Grand Canyon Education | $229M | 20.7% | +7.9% | FY2025 |
| 211 | Garmin | $229M | 3.2% | +19.3% | FY2025 |
| 212 | Neurocrine Biosciences | $227M | 7.9% | +18.7% | FY2025 |
| 213 | McCormick | $225M | 3.3% | +2.9% | FY2025 |
| 214 | Peloton Interactive | $224M | 9.2% | -9.2% | FY2026 |
| 215 | Dexcom | $224M | 4.8% | +15.2% | FY2025 |
Full ranking of 336 companies · Biggest increases #82 · Up 5+ years in a row #20
Questions
How much does Neurocrine Biosciences spend on advertising?
Neurocrine Biosciences spent $227M on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 11, 2026.
What percentage of revenue does Neurocrine Biosciences spend on advertising?
7.9% of revenue in fiscal 2025 ($227M of $2.9B). The median across the 336 companies tracked is 5.2%.
Is Neurocrine Biosciences spending more on advertising?
Yes. Ad spend rose 18.7% in fiscal 2025 from fiscal 2024. It has risen 7 years in a row.
How does Neurocrine Biosciences rank by advertising spend?
#212 of 336 US-listed companies with $100M or more in ad spend, ranked on each company's latest fiscal year.
What does Neurocrine Biosciences's advertising figure include?
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Source
- Filing
- 10-K for FY2025, filed Feb 11, 2026
- Accession number
0000914475-26-000007- Company
- NEUROCRINE BIOSCIENCES INC, CIK 914475, SIC 2836 (Biological Products, (No Diagnostic Substances))
- Data
- SEC EDGAR XBRL company facts, retrieved Nov 4, 2026. Methodology.
- Cite
- Neurocrine Biosciences advertising spend, FY2018-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 11, 2026), retrieved Nov 4, 2026. https://io.trudov.com/company/neurocrine-biosciences/advertising-spend/
- Download
- CSV, all years · CSV, all 336 companies